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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYIt has been shown that themammary luminal lineage could bemaintained by luminal stem cells or long-lived progenitors, but their iden-
tity and role in breast cancer remain largely elusive. By lineage analysis usingWap-Cremice, we found that, in nulliparous females, mam-
mary epithelial cells (MECs) genetically marked byWap-Cre represented a subpopulation of CD61+ luminal progenitors independent of
ovarian hormones for their maintenance. Using a pulse-chase lineage-tracing approach based onWap-Cre adenovirus (Ad-Wap-Cre), we
found that Ad-Wap-Cre-marked nulliparous MECs were enriched with CD61+ alveolar progenitors (APs) that gave rise to CD61 alveolar
luminal cells during pregnancy/lactation and could maintain themselves long term. When transformed by different oncogenes, they
could serve as cells of origin of heterogeneous mammary tumors. Thus, our study revealed a type of long-lived AP within the luminal
lineage that may serve as the cellular origin of multiple breast cancer subtypes.INTRODUCTION
Breast cancer is heterogeneous and can be divided into at
least sixmolecular subtypes with distinct clinical outcomes
(Perou et al., 2000; Prat et al., 2010; Sorlie et al., 2003). The
current hypothesis is that this heterogeneitymainly results
from the interplay of different cells of origin and transfor-
mation events (Visvader, 2011). Studies in both human
cells andmurinemodels have implied that basal mammary
epithelial cells (MECs), luminal progenitors (LPs), and
more mature luminal MECs may be cells of origin of the
Claudin-low, Basal-like, and Luminal subtypes of breast
cancers, respectively (Skibinski and Kuperwasser, 2015).
However, definitive evidence to support this remains
largely elusive. As target cells of breast tumorigenesis,
MECs are composed of the luminal and basal/myoepithe-
lial lineages. The luminal lineage can be further divided
into a ductal and an alveolar sub-lineage. Studies based
on cleared mammary fat pad transplantation have shown
that a single multipotent mammary stem cell (MaSC),
which is a basal MEC, could reconstitute the entire mam-
mary epithelium in the recipient (Shackleton et al., 2006;
Stingl et al., 2006). Transplantation studies based on
limiting dilutions of MECs also revealed the presence of
duct-limited progenitors, which produced both ductal
luminal and ductal myoepithelial cells as well as lobule-
limited progenitors that gave rise to secretory alveolar
luminal cells (ALs) and alveolar myoepithelial cells (Kor-
don and Smith, 1998; Smith, 1996). In support of the pres-
ence of lobule-limited biopotent progenitors, a population
of lobule-restricted cells termed parity-induced MECs60 Stem Cell Reports j Vol. 5 j 60–74 j July 14, 2015 j ª2015 The Authors(PI-MECs) was defined previously based on genetic
marking using theWap-Cre (Whey Acidic Protein [Wap] pro-
moter-driven Cre expression) transgenic mouse and a con-
ditional Cre-reporter (Rosa26-loxP-Stop-loxP-lacZ [R26lz])
(Figure 1A; Boulanger et al., 2005;Wagner et al., 2002). Spe-
cifically, PI-MECs were identified in parous females as lacZ+
alveolar cells that survived involution and could serve as
multipotent mammary stem/progenitor cells to produce
new secretory acini, composed of both secretory luminal
and myoepithelial cells, in the subsequent pregnancies;
furthermore, transplantation assays revealed that PI-
MECs weremultipotent and could self-renew overmultiple
rounds of transplantations (Boulanger et al., 2005).
Transplantation assays, which measure the potential of
cells under investigation, traditionally were used as the
gold standard for characterizing tissue stem cells. However,
recent studies in epithelial tissues based on pulse-chase
lineage-tracing approaches, which measure the activity of
primary cells in their native habitats, often revealed a
discrepancy in the phenotype of an epithelial stem cell
population when different assays were used (Choi et al.,
2012; Van Keymeulen et al., 2011; Wang et al., 2013). In
the mammary gland (MG), lineage-tracing studies based
on MEC lineage-specific CreER (Cre-estrogen receptor
fusion) mice demonstrated that adult luminal and basal
lineages are largely self-sustained (Prater et al., 2014; van
Amerongen et al., 2012; Van Keymeulen et al., 2011); in
particular, in unperturbed tissues, the luminal lineage ap-
pears to be maintained largely by its own lineage-restricted
luminal stem cells (LuSCs), rather than by basal MaSCs
(Van Keymeulen et al., 2011). However, more recent
lineage-tracing studies provided new evidence of the exis-
tence of both bipotent basal MaSCs and distinct long-lived
LPs to support homeostasis of the luminal lineage in the
physiological setting (Rios et al., 2014; Wang et al., 2015).
Collectively, these studies reflect the intrinsic complexity
of the MEC hierarchy that operates in vivo and a need to
further dissect the MEC hierarchy in the physiological
setting. Furthermore, since most promoters used in previ-
ous lineage-tracing studies either target a broad range of
MECs or are subject to developmental stage-dependent
regulation, it is difficult to use these genetic tools to directly
determine the cell of origin of breast cancer and how the
cellular origin contributes to breast cancer heterogeneity.
In this study, we analyzed a narrower MEC lineage (i.e.,
the alveolar luminal sub-lineage) defined based on genetic
marking by Cre expression controlled by the same Wap
promoter (Wagner et al., 1997), a MEC-specific promoter
frequently used in breast cancermousemodels.We provide
evidence for a long-lived luminal MEC subpopulation en-
riched with alveolar-committed progenitors thatmay serve
as the cell of origin of multiple breast cancer subtypes.RESULTS
Wap-Cre-Marked Cells in Nulliparous MGs Are
Luminal MECs Expressing LP Markers
PI-MECs, as the name suggests, were originally identified in
parous females asWap-Cre-marked multipotent mammary
stem/progenitor cells thatmight be derived from the de-dif-
ferentiation of secretory alveolar cells (Boulanger et al.,
2005;Wagner et al., 2002). Later it was found that such cells
(i.e., lacZ+ MECs genetically marked byWap-Cre) also were
present in nulliparous (virgin) MGs (thus, the term ‘‘PI-
MECs’’ now refers to parity-identified MECs) (Booth et al.,
2007). However, these lacZ+ cells from the virgin gland
were only detected in mammary explant cultures in the
presence of insulin, so it was uncertain whether they were
also present in nulliparous Wap-Cre;R26lz MGs in vivo. It
has been well documented that theWap promoter is active
at estrus, but not at diestrus, in virgin females (e.g., based on
a Wap-lacZ transgenic mouse model [Robinson et al.,
1995]). However, lacZ+ MECs detected inWap-lacZ females
are not equivalent to lacZ+ MECs found inWap-Cre;R26lz fe-
males, as the latter only require transient expression of Cre
(to irreversibly turn on the lacZ reporter) from theWap pro-
moter, and they can be either long-lived cells (with tran-
sientWap expression) or progeny cells that inherit the acti-
vated lacZ allele from their Wap+ parental MECs. We
reasoned that if someof theseWap-Cre-markedMECs in vir-
gin glands are stem cells or long-lived progenitors, they
might be detected by more sensitive genetic-marking ap-
proaches (due to their long-lived nature).To test this hypothesis, we crossed Wap-Cre mice to a
conditional Cre-reporter, Rosa26-loxP-Stop-loxP-YFP
(R26YFP) (Figure 1A), which allows robust lineage-tracing
and clonal analysis of MECs in vivo by immunostaining
and fluorescence-activated cell sorting (FACS) (Tao et al.,
2014; Van Keymeulen et al., 2011). In Wap-Cre;R26YFP
(but not in R26YFP-only) adult virgin females, we could
consistently detect a small population of YFP+ MECs,
although under the FVB background the percentage of
YFP+ MECs was at least 10-fold higher than that under
the C57Bl/6 background (Figures 1B, S1A, and S1B). This
profound strain difference might partially explain the dif-
ficulty in consistently detecting theWap-Cre-marked MEC
population in virgin females previously (Booth et al.,
2007; Boulanger et al., 2005; Matulka et al., 2007; Wagner
et al., 2002). Upon gating for LinYFP+ (Lin: lineage
markers) cells, we found that these YFP+ cells were almost
entirely within the LinCD24hiCD29med luminal gate (Fig-
ures 1C and S1C); the majority of them were positive for
all known LP markers, including CD61, CD14, C-KIT,
and CD49B (Asselin-Labat et al., 2007, 2011; Li et al.,
2009), and they were negative for mature luminal cell
(ML, i.e., estrogen receptor [ER]-positive cells) markers,
including SCA-1 and CD133 (Prominin 1) (Sleeman
et al., 2007; Figures 1C and S1D). Thus, these YFP-marked
MECs appear to largely overlap with the SCA-1CD49B+
LP subpopulation described recently, which is analogous
to the ALDH+ LP subpopulation in the human breast (She-
hata et al., 2012).
Immunofluorescence (IF) staining for YFP revealed that
these YFP+ cells were indeed K8+K14 luminal MECs (Fig-
ure 1D). Immunohistochemistry (IHC) staining and clonal
analysis further revealed thatmost YFP+ cells were localized
in mammary ducts and alveoli as single-cell or two-cell
clones interspersed by YFP luminal MECs (Figures 1E,
1F, and S1E), whereas larger clones with more than two
YFP+ cells were often found in alveoli (Figure 1F). FACS
isolation of these YFP+ cells and subsequent IF staining
further confirmed that they were exclusively K8+K14K5
luminal MECs (Figure 1G). Since LinCD24+CD133+ (or
SCA-1+) MECs were shown enriched with ER+ cells (Slee-
man et al., 2007), and a small portion of YFP+ cells from
Wap-Cre;R26YFP virgin females were CD133+ (and
SCA-1+), we sorted the CD133+ or CD133 subsets from
YFP+ or YFP MECs from the same mice, and, by qRT-
PCR analysis, we found that YFP+CD133+ MECs exhibited
a low level of Esr1 expression comparable to that of
CD133 MECs, which are known to be enriched in ER
MECs (Sleeman et al., 2007; Figure 1H). Together, these
data suggest that Wap-Cre genetically marks a subpopula-
tion of MECs in nulliparous mammary ducts and alveoli
that are exclusively luminal cells, express all known cell
surface markers of LPs, and are ER negative.Stem Cell Reports j Vol. 5 j 60–74 j July 14, 2015 j ª2015 The Authors 61
Figure 1. WVs Are Luminal Cells Expressing LP Markers
(A) Schematic diagram shows Cre-mediated excision of a floxed Stopper cassette (Stop) in a conditional reporter leads to expression of the
reporter (Marker, YFP or lacZ); the cell-type specificity is achieved through the promoter (e.g., Wap) that controls Cre expression.
(B) FACS plots show percentages of YFP-marked Lin cells in MGs isolated from Wap-Cre;R26YFP virgin females on distinct genetic
backgrounds (C57Bl6 [left], FVB [middle], or R26YFP control [FVB, right]). See also Figure S1B.
(C) FACS profiles of YFP-marked Lin cells isolated from adultWap-Cre;R26YFP virgin females (FVB) for the indicated markers are shown. Lu,
luminal gate; Ba, basal gate; Str, stromal cell gate. FACS gating strategy is shown in Figure S1C; detailed quantification of the percentage of
each gate is shown in Figure S1D.
(D) IF staining for YFP on MG sections of adult Wap-Cre;R26YFP virgin females is shown. Scale bar, 50 mm.
(legend continued on next page)
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Wap-Cre-Marked Nulliparous MECs Represent a
Subpopulation of LPs Independent of Ovarian
Hormones for Their Maintenance
To further determine the identity ofWap-Cre-markedMECs
in virgin females (referred to as ‘‘WVs’’) at the molecular
level, we sorted YFP+ WVs as well as MaSCs, LPs, and MLs
(MEC subsets defined based on Lim et al. [2010]) from
Wap-Cre;R26YFP virgin females; as a control, we also sorted
YFP+MECs fromWap-Cre;R26YFP females atmid-gestation,
which are enrichedwith differentiatingCD61ALs (Figures
S2A and S2B).We then profiled these sortedMEC subsets by
microarray. By principal-component analysis (PCA), we
found that the cluster ofWVs exhibited the closest distance
to that of LPs (Figure 2A). To validate this observation, we
selected several marker genes that were shown previously
to mark different MEC subsets and are conserved between
human and mouse (Lim et al., 2010), and we confirmed by
qRT-PCR that WVs exhibited an expression pattern similar
to that of the bulk of LPs (Figure 2B). Since LPs were sorted
basedonCD61 (Limet al., 2010), theyappeared to represent
a mixed population of heterogeneous progenitor cells for
ductal luminal cells and ALs (Shehata et al., 2012). To deter-
minewhetherWVs represent a subpopulationof thehetero-
geneous CD61+ LPs, we compared the microarray expres-
sion profile of WVs to that of LPs. By gene set enrichment
analysis (GSEA) (Subramanian et al., 2005), we found that,
compared to the bulk of CD61+ LPs, gene ontology (GO)
terms related to activities of receptors (in plasma mem-
brane) and responses to external stimuli, as well as those
related to amino acid metabolism, were enriched in WVs
(Figure 2C), whereas those related to RNA processing were
downregulated in WVs (i.e., WVs may be less active
compared to the bulk of LPs) (Figure 2D). Together, these
data suggest that WVs may represent a subpopulation of
CD61+ LPs.
Our strategy to visualize WVs is based on Cre expression
from theWap-Cre transgene in nulliparous MGs; once they
are genetically marked by YFP, theWap promoter activity is
not needed any more. Although the Wap promoter is a
well-known promoter that responds to steroid hormones
(Robinson et al., 1995), this does not necessarily indicate
that maintenance of WVs also is dependent on ovarian(E) Percentages of YFP-marked clones composed of single cell, doublet
of Wap-Cre;R26YFP females are shown (n = 4 mice). Data represent m
(F) IHC (brown cells, YFP+ cells) staining for YFP on MG sections of ad
structure budding out from a mammary duct, and most luminal MECs i
Scale bar, 20 mm.
(G) IF staining for K5, K14, and K8 on LinYFP+ cells sorted fromWap-C
were used as the control. Scale bars, 100 mm.
(H) Expression levels of Esr1 in the indicated populations sorted from
represent mean ± SEM (*p < 0.001, #p < 0.005).
See also Figure S1.hormones. To test this notion, we performed bilateral
ovariectomy on Wap-Cre;R26YFP adult virgin females. We
found that, after ovariectomy, a population of YFP+ MECs
similar to that in intact females could still be detected,
and these ovarian hormone-independent YFP+ MECs re-
mained in the luminal gate (Figures S2C–S2E). These data
suggest that ovarian hormones are not required for the
maintenance of WVs. A previous study demonstrated
that PI-MECs analyzed in parous females also share this
property (Matulka et al., 2007).
Ad-Wap-Cre-Marked Nulliparous MECs Contain Long-
Lived Progenitors that Exhibit Spontaneous Alveolar
Differentiation in Virgin Females
InWap-Cre;R26YFP females, since theWap-Cre transgene is
constitutive, it is not possible to perform longitudinal
studies to determine the lineage relationship between
ductal and alveolar localized WVs in nulliparous MGs, as
well as that betweenWVs and YFP+ CD61ALs in pregnant
and lactating females. A pulse-chase lineage-tracing system
that can allow us to control the timing of Cre expression
from theWappromoter is necessary. To achieve this, we uti-
lized a pulse-chase lineage-tracing system we established
recently based on intraductal injection of lineage-specific
Cre-expressing adenovirus (Ad-Cre) (Tao et al., 2014).
Adenovirus is a DNA virus that does not integrate into
the host genome and the adenoviral vector we use only
leads to transient protein expression; thus, it serves a
similar purpose as an inducible Cre system for pulse-chase
lineage tracing.
We generated an Ad-Cre virus using the same Wap pro-
moter as in Wap-Cre mice (Wagner et al., 1997) (Ad-Wap-
Cre). We injected Ad-Wap-Cre into mammary ducts of
R26YFP females at the virgin stage (pulse labeling at
2 months of age) and analyzed YFP-marked MECs in vir-
gin females at several time points thereafter (Figure 3A).
To determine the specificity of genetic marking by Ad-
Wap-Cre, we sorted YFP+ MECs 3 days after injection (i.e.,
freshly labeledWVs). As an internal control, we also sorted
CD61+ LPs (i.e., the bulk of the LP population) from the
same animals. By qRT-PCR, we found that WVs expressed
a higher level of the endogenousWap than LPs (Figure 3B),, or more than two cells quantified from YFP-IHC-stained MG sections
ean ± SEM.
ult Wap-Cre;R26YFP virgin females. Red arrow indicates an alveolar
n it are YFP+. Green arrows indicate interspersed YFP+ luminal cells.
re;R26YFP virgin females is shown; unsorted cells from the same MGs
adult Wap-Cre;R26YFP virgin females are shown (n = 3 mice). Data
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RANK NAME NES NOM p-val FDR q-val
1 RESPONSE_TO_WOUNDING 2.12 0 0.0086
2
HEMATOPOIETIN_INTERFERON_CLASSD200_DOMAIN_CYTOKINE_
RECEPTOR_ACTIVITY 2.12 0 0.0049
3 IMMUNE_RESPONSE 2.10 0 0.0057
4 RESPONSE_TO_EXTERNAL_STIMULUS 2.10 0 0.0043
5 INFLAMMATORY_RESPONSE 2.05 0 0.0102
6 DEFENSE_RESPONSE 2.03 0 0.0128
7 AMINO_ACID_METABOLIC_PROCESS 2.00 0 0.0163
8 NITROGEN_COMPOUND_CATABOLIC_PROCESS 2.00 0 0.0144
9 IMMUNE_SYSTEM_PROCESS 1.99 0 0.0147
10 OXYGEN_BINDING 1.97 0 0.0206
11 INTEGRAL_TO_PLASMA_MEMBRANE 1.96 0 0.0206
12 INTRINSIC_TO_PLASMA_MEMBRANE 1.95 0 0.0218
13 MULTICELLULAR_ORGANISMAL_DEVELOPMENT 1.94 0 0.0224
14 PLASMA_MEMBRANE_PART 1.94 0 0.0210
15 AMINO_ACID_AND_DERIVATIVE_METABOLIC_PROCESS 1.93 0 0.0245
16 PLASMA_MEMBRANE 1.92 0 0.0281
17 RECEPTOR_ACTIVITY 1.91 0 0.0291
18 EXTRACELLULAR_REGION 1.90 0 0.0291
19 LIPID_RAFT 1.89 0 0.0326
20 LOCOMOTORY_BEHAVIOR 1.89 0 0.0324
21 INTRINSIC_TO_MEMBRANE 1.88 0 0.0326
22 EXTRACELLULAR_SPACE 1.88 0 0.0322
23 AMINE_CATABOLIC_PROCESS 1.88 0.00660066 0.0314
24 INTEGRAL_TO_MEMBRANE 1.88 0 0.0302
25 AMINE_METABOLIC_PROCESS 1.87 0 0.0341
RANK NAME NES NOM p-val FDR q-val
1 MRNA_PROCESSING_GO_0006397 -2.06 0 0.0702
2 STRUCTURAL_CONSTITUENT_OF_RIBOSOME -2.02 0 0.0548
3 RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS_AND_ASSEMBLY -1.98 0 0.0689
4 RIBONUCLEOPROTEIN_COMPLEX -1.96 0 0.0651
5 RNA_PROCESSING -1.96 0 0.0535
6 NUCLEAR_PORE -1.95 0 0.0480
7 ENDONUCLEASE_ACTIVITY_GO_0016893 -1.92 0.0023 0.0548
8 NUCLEOLAR_PART -1.91 0.0023 0.0573
9 RIBOSOME_BIOGENESIS_AND_ASSEMBLY -1.89 0 0.0655
10 CYTOSKELETON_DEPENDENT_INTRACELLULAR_TRANSPORT -1.88 0.0048 0.0627
11 NUCLEOLUS -1.87 0 0.0608
12 RNA_SPLICING -1.85 0 0.0725
13 RRNA_PROCESSING -1.84 0.0023 0.0742
14 DNA_INTEGRITY_CHECKPOINT -1.83 0 0.0774
15 RNA_SPLICINGVIA_TRANSESTERIFICATION_REACTIONS -1.81 0.0076 0.0886
16 TRNA_METABOLIC_PROCESS -1.79 0.0118 0.0981
17 CONDENSED_CHROMOSOME -1.79 0.0025 0.0947
18 ACTIN_FILAMENT_BASED_MOVEMENT -1.74 0.0069 0.1446
19 PORE_COMPLEX -1.74 0.0078 0.1373
20 RIBONUCLEASE_ACTIVITY -1.73 0.0117 0.1382
21 DNA_DAMAGE_CHECKPOINT -1.71 0.0096 0.1551
22 CONDENSED_NUCLEAR_CHROMOSOME -1.69 0.0112 0.1789
23 SMALL_NUCLEAR_RIBONUCLEOPROTEIN_COMPLEX -1.68 0.0149 0.1783
24 SPLICEOSOME -1.68 0.0102 0.1796
25 ENDORIBONUCLEASE_ACTIVITY -1.67 0.0231 0.1837
C
D
A
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Figure 2. WVs Represent a Subpopulation of CD61+ LPs
(A) PCA of microarray data for distinct subsets of MECs shows WVs clustered more closely with LPs.
(B) qRT-PCR analysis confirmed the expression pattern of a number of well-known markers for different sorted MEC subsets (n = 4 mice).
WVs, YFP-marked MECs from adult Wap-Cre;R26YFP virgin females; MaSC, mammary stem cell; LP, luminal progenitor; MLs, mature luminal
cells; ALs, alveolar luminal cells (i.e., YFP-marked MECs from Wap-Cre;R26Y mice at mid-gestation). Data represent mean ± SEM.
(C and D) GSEA shows the top 25 enriched GO terms in WVs (C) and LPs (D), respectively. NES, normalized enrichment score; NOM p-val,
nominal p value. False discovery rate (FDR) q value% 0.25 was considered as significant.
See also Figure S2.suggesting that the initial genetic marking is based on the
specific activity of theWap promoter, rather than non-spe-
cific labeling. To determine whether newly labeledWVs are
similar to WVs in Wap-Cre;R26YFP virgin females at the
molecular level, we measured expression levels of select
markers in WVs (2 weeks post-injection) by qRT-PCR and
found that they exhibited a similar LP gene expression
pattern (Figure S3). By clonal analysis, we found that,
3 days after Ad-Wap-Cre injection, the majority of YFP+
clones were found in mammary ducts (Figure 3C, 75%
in mammary ducts and 25% in alveoli), and most of
them were small clones (Figure 3D). Interestingly, after a
long-term chase (4.5 months), we found that more YFP+64 Stem Cell Reports j Vol. 5 j 60–74 j July 14, 2015 j ª2015 The Authorsclones were found in alveoli than in mammary ducts (Fig-
ure 3C, 40% in mammary ducts and 60% in alveoli),
and most of the alveolar-localized clones were large clones
(Figures 3D–3H). These data suggest that freshly labeled
WVs contain long-lived progenitors committed to the alve-
olar lineage (i.e., alveolar progenitors [APs]).
Ad-Wap-Cre-Marked Nulliparous MECs Are Enriched
with APs that Give Rise to Differentiating ALs during
Pregnancy/Lactation and Are Self-Sustained over the
Long Term
Although in virgin females we showed that freshly labeled
WVs had a tendency to undergo spontaneous alveolar
Figure 3. Freshly Labeled WVs Contain
Long-Lived Progenitors that Exhibit
Spontaneous Alveolar Differentiation in
Nulliparous Females
(A) Timeline of pulse-chase lineage tracing
by Ad-Wap-Cre intraductal injection into
R26YFP nulliparous MGs. Animals were kept
as virgins.
(B) qRT-PCR analysis shows higher expres-
sion of the endogenous Wap in freshly
labeled WVs (WV) in relation to the bulk of
CD61+ LPs (LP) (pooled sorted cells from ten
injected MGs from five mice). Expression
was normalized to Actb. Data represent
mean ± SEM (from three technical repli-
cates).
(C and D) Relative percentages of YFP+
ductal and alveolar clones (total = 100%)
3 days or 4.5 months (m) after injection (C)
and distributions of small (1–2 cells), in-
termediate (3–5 cells), and large (>5 cells)
YFP+ clones in the indicated MG sections
(D). Relative percentages of YFP+ ductal and
alveolar clones at each indicated chase time
point (total = 100%) are shown. Data
represent mean ± SEM; n = 4 (3 days) and 5
(4.5 months) injected MGs from three mice
each.
(E–H) Representative IF pictures show
ductal (E and G) or alveolar (F and H)-
localized YFP+ clones (arrowheads) 3 days
(E and F) or 4.5 months (G and H) after
injection.
See also Figure S3.differentiation (Figures 3C–3H), we reasoned that their full
potential would only be revealed upon pregnancy and
lactation. We therefore injected Ad-Wap-Cre into mam-
mary ducts of 2-month-old R26YFP virgin females and
then allowed them to go through one or multiple rounds
of pregnancy and lactation. We analyzed the YFP-marked
lineage in them at different stages ofMGdevelopment (Fig-
ure 4A). At both mid-gestation and lactation stages, by
clonal analysis, we observed individual alveoli composed
of almost entirely YFP+ MECs (Figures 4B and 4C), and
only ALs (but not alveolarmyoepithelial cells) weremarked
by YFP (Figures S4A and S4B). These data suggest that at
least a portion of freshly labeled WVs at the virgin stageare APs that clonally give rise to ALs during pregnancy
and lactation.
Since many freshly marked WVs are localized in mam-
mary ducts (Figures 3C–3H), it is uncertain whether such
ductal-localized WVs are APs that produce ALs during
pregnancy. To determine this, we generated a cohort of
R26YFP females by injecting Ad-Wap-Cre and Ad-K8-Cre vi-
ruses to the contralateral sides of inguinal MGs in the same
mouse, respectively, at the virgin stage. K8 (Keratin 8) is a
pan-luminal marker and we showed previously that intra-
ductal injection of Ad-K8-Cre led to genetic marking of
the entire luminal lineage, including both ductal progeni-
tors and APs (Tao et al., 2014). To account for the differenceStem Cell Reports j Vol. 5 j 60–74 j July 14, 2015 j ª2015 The Authors 65
Figure 4. Freshly Labeled WVs Are Enriched with Self-Sustained, Clonogenic APs
(A) Timeline shows pulse-chase lineage tracing by Ad-Wap-Cre intraductal injection into R26YFP nulliparous MGs.
(B and C) IF staining of MG sections shows alveoli formed by YFP+ cells (induced by Ad-Wap-Cre injection at the virgin stage) during mid-
gestation (B) and lactation (C). Scale bars, 50 mm. Note only K8+ ALs, but not K14+ myoepithelial cells, were labeled by YFP (see also
Figures S4A and S4B).
(legend continued on next page)
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in the intrinsic labeling efficiency of different adenovi-
ruses, we titrated Ad-K8-Cre so that the initial labeling
(measured as the percentage of YFP+ cells) was similar to
that of Ad-Wap-Cre. Upon chasing to mid-gestation, we
found that the majority of YFP+ clones from Ad-K8-Cre in-
jection were ductally localized, whereas most YFP+ clones
from Ad-Wap-Cre injection were found in alveoli (Fig-
ure 4D, overall quantifications; Figures S4C and S4D, repre-
sentative IF pictures). Furthermore, we found that the ma-
jority of YFP+ clones inAd-Wap-Cre-markedMGswere large
alveolar clones (i.e., more than five cells) (Figure 4E). We
showed previously that, when injected using a higher viral
titer, Ad-K8-Cre-marked luminal MECs at the virgin stage
also could give rise to similar large alveolar clones at mid-
gestation (Tao et al., 2014). The enrichment of alveolar
clones in Ad-Wap-Cre-marked MGs at mid-gestation could
be explained by two possibilities. One possibility is that a
significant portion of the freshly labeled, ductal-localized
WVs were indeed APs that gave rise to alveolar clones at
mid-gestation. The second possibility is that YFP+ alveolar
clones at mid-gestation were mainly derived from freshly
labeled, alveolar-localized WVs, whereas most of the
freshly labeled ductal WVs were not maintained and disap-
peared at mid-gestation. Since the majority of freshly
labeled WVs were ductal cells by location (Figure 3C), if
they were not maintained, we would expect to observe a
significant reduction in the total number of YFP+ clones
at mid-gestation compared to that from Ad-K8-Cre-marked
MGs (as Ad-K8-Cre not only marks ductal WVs, but also
other ductal MECs not targeted by Ad-Wap-Cre). However,
we noted that, at mid-gestation, the total numbers of YFP+
clones in Ad-K8-Cre-marked and Ad-Wap-Cre-marked MGs
were not significantly different (Ad-Wap-Cre, 83 ± 7;
Ad-K8-Cre, 99 ± 20; p value = 0.43; Figure 4E), which
thus largely ruled out the second possibility. Overall,
our lineage-tracing data demonstrate that Ad-Wap-Cre-
marked nulliparous MECs (i.e., WVs) are enriched with
clonogenic APs.
To further characterize the Ad-Wap-Cre-marked lineage,
we performed FACS analysis.We found that, 3 days post-in-
jection, almost all YFP+ MECs were localized in the luminal
gate and most of them were positive for the LP markers
CD61 and C-KIT (Figure 4F, ii and iv). Upon chasing to
mid-gestation and lactation, we found that most YFP+(D and E) Relative percentages of YFP+ ductal and alveolar clones (tot
Cre [control] injection at the virgin stage) (D) and distributions of sm
clones in the indicated mid-gestation MG sections (E). Relative percen
100%) are shown. K8, Ad-K8-Cre; WAP, Ad-Wap-Cre. Data represent mea
WAP injected to the contralateral sides of inguinal MGs in each mous
(F) FACS analysis of R26YFP virgin females injected with Ad-Wap-Cre c
Ba, basal gate; Str, stromal cell gate. Detailed quantification of the p
See also Figure S4.MECs became CD61 differentiating (and proliferating)
ALs, although important, a small subset of them remained
as CD61+ cells (Figure 4F, viii and xii). Of note, a small
population of CD61+ YFP+ MECs also was observed in
Wap-Cre;R26YFP females at mid-gestation (Figures S2A
and S2B). Following involution, the YFP+ cells reverted to
the nulliparous state and appeared as CD61+ LPs again
(Figure 4F, xiv and xvi). These data (Figures 4F and S4E)
suggest that theAd-Wap-Cre-markedWVsundergo full alve-
olar differentiation during pregnancy/lactation and may
maintain themselves as long-lived APs after lactation/
involution.
To further demonstrate the long-lived nature and differ-
entiation property of WVs, we injected Ad-Wap-Cre to
virgin females carrying the above-described conditional
Cre-reporter R26lz. During lactation of the first pregnancy
or after multiple rounds of pregnancy, we could observe
large lobules composed of lacZ+ cells (Figure S4F). Similarly,
we also could detect YFP+ luminal MECs in R26YFP females
after multiple rounds of pregnancy, upon injection of Ad-
Wap-Cre at the virgin stage (Figure S4G). Collectively, our
lineage-tracing data suggest that WVs in the virgin MG
are enriched with a pre-existing population of long-lived
APs, in the physiological setting.
WVs Can Serve as Cells of Origin of Luminal
Mammary Tumors
It was suggested previously that PI-MECs were the pri-
mary targets of neoplastic transformation in multiple
MMTV-promoter-driven breast cancer models, including
MMTV-Neu and MMTV-PyMT models (Henry et al., 2004;
Jeselsohn et al., 2010), both of which develop luminal
mammary tumors (Pfefferle et al., 2013). However, since
PI-MECs were initially proposed as MECs induced by par-
ity, it was uncertain whether WVs that are present in
nulliparous MGs could serve as direct cells of origin in
them. To address this, we bred these two models to
Wap-Cre and R26YFP mice and generated MMTV-(Neu or
PyMT);Wap-Cre;R26YFP triple transgenic females. We
found that most mammary tumors that developed in
these triple-transgenic virgin females were indeed YFP+
(Figures 5A and S5A). In both models, at the premalignant
stage, we could already observe significant expansion of
YFP-marked MECs, and all these YFP+ premalignantal = 100%) in mid-gestation MGs (induced by Ad-Wap-Cre or Ad-K8-
all (1–2 cells), intermediate (3–5 cells), and large (>5 cells) YFP+
tages of YFP+ ductal and alveolar clones from each injection (total =
n ± SEM; n = 4 (K8) and 5 (WAP) injected MGs from five mice (K8 and
e, respectively).
hased to different developmental stages is shown. Lu, luminal gate;
ercentage of each gate is shown in Figure S4E.
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Figure 5. WVs Can Be Cells of Origin of
Luminal Mammary Tumors
(A) Most tumors developed in MMTV-Neu;
Wap-Cre;R26YFP and MMTV-PyMT;Wap-Cre;
R26YFP virgin females were YFP+ (i.e., >50%
YFP+Lin cells in a tumor; see Figure S5A).
(B) Timeline to chase the cellular origin of
MMTV-PyMT mammary tumor based on ge-
netic marking by Ad-Wap-Cre intraductal
injection is shown.
(C and D) IF staining of induced YFP+ cells
1 week after Ad-Wap-Cre injection. While
some YFP-marked cells remained compara-
tively normal (C), others began to form YFP+
K8+K14 in situ hyperplasia (D). Scale bars,
50 mm.
(E) IF staining of YFP+ K8+K14 adenocar-
cinomas induced by Ad-Wap-Cre injection.
Note that adenocarcinomas were either
completely YFP+ or YFP. Scale bar, 50 mm.
See also Figure S5.MECs remained restricted to the luminal lineage (Fig-
ure S5B). These data supported that WVs could serve as
cells of origin in these models when kept as virgin
females.
To more definitively determineWVs as cells of origin, we
focused on the MMTV-PyMT model. We injected Ad-Wap-
Cre to MMTV-PyMT;R26YFP virgin females (to mark WVs
by YFP, Figure 5B) at 4 weeks of age when their MGs still ap-
peared normal (Figure S5C). At 1 week post-injection, in
addition to individual YFP-marked luminal MECs (Fig-
ure 5C), we also observed clones of YFP+ premalignant
K8+K14 luminal cells starting to emerge in mammary
ducts (Figure 5D). At 3 weeks post-injection, we detected
K8+K14 luminal mammary tumors that were either
entirely positive or negative for YFP (Figure 5E), suggesting
that each tumor was clonally derived from its cell of origin,
either marked by Ad-Wap-Cre or not. These data thus pro-
vide direct evidence to support that (Ad-)Wap-Cre-marked
WVs are cells of origin of luminal mammary tumors in
the MMTV-PyMT model.68 Stem Cell Reports j Vol. 5 j 60–74 j July 14, 2015 j ª2015 The AuthorsWVs Can Serve as Cells of Origin of Mammary Tumors
with Basal Differentiation
We showed previously thatWap-Cre-mediated activation of
the conditional Etv6-NTRK3 (EN) knockin allele in virgin
females led to the development of mammary tumors
with basal differentiation. These tumors were either
composed of K8+K14/low luminal tumor cells surrounded
by (and/or mixed with) K5+K14+ basal tumor cells (type I
tumors) or composed of K8+K14+K5 tumor cells (type II
tumors) (Li et al., 2007). Since we showed that WVs are
K8+K14 CD61+ luminal cells (Figures 1 and 2), we asked
whether activation of EN led to abnormal luminal-to-basal
differentiation directly from WV luminal cells. To deter-
mine this, we used two genetic-marking approaches. In
the first approach, we generatedWap-Cre;EN;R26YFP virgin
females and checked their MGs at the premalignant stage.
We observed a significant portion of YFP+ premalignant
MECs emerged in the basal gate, compared to premalig-
nant MECs in MMTV-(Neu or PyMT);Wap-Cre;R26YFP vir-
gin females, which were almost entirely restricted to the
Figure 6. WVs Can Be Cells of Origin of
Mammary Tumors with Basal Differentia-
tion
(A) EN mice induced by Ad-Wap-Cre (n = 6)
showed similar tumor latency as Wap-Cre;EN
mice (n = 10); both cohorts had the same
FVB background.
(B and C) IF staining confirmed that the two
tumor types (type I, B; type II, C) originally
identified in Wap-Cre;EN mice were reca-
pitulated in EN mice induced by Ad-Wap-
Cre. Scale bars, 50 mm.
(D and E) IF staining of EN;R26YFPMGs after
Ad-Wap-Cre intraductal injection showed
abnormal basal differentiation during the
preneoplastic stage. (D) Most YFP+ preneo-
plastic clones contained K8+K14+ cells. (E)
Some YFP+ clones contained largely
K8K14+ basal cells mixed with a few
K8+K14 luminal cells. Scale bars, 50 mm.
See also Figure S6.luminal gate (Figure S5B). To further confirm this, we sorted
YFP+ MECs from Wap-Cre;EN;R26YFP premalignant MGs,
and, by IF staining, we indeed detected MECs with basal
differentiation (i.e., K14+K8 and K14+K8+ cells), in addi-
tion to K14K8+ luminal cells (Figure S5D).
To definitively proveWV luminal cells as cells of origin of
EN mammary tumors with basal differentiation, we in-
jected Ad-Wap-Cre tomammary ducts of virgin females car-
rying the same EN conditional allele and found that all in-
jected females developed mammary tumors with a latency
similar to that of Wap-Cre;EN females (both under FVB
background) (Figure 6A). By IF staining, we found that
the two types of tumors (i.e., types I and II) developed in
our original Wap-Cre;EN mouse model (Li et al., 2007)
were both recapitulated (Figures 6B, 6C, and S6). These
new data thus provide direct evidence to support WVs
as the cellular origin in this tumormodel. Nextwe analyzed
the Ad-Wap-Cre-injected EN;R26YFP MGs with premalig-
nant lesions. By IF staining, we detected YFP+ lesions
composed of K14+K8+ MECs, as well as YFP+ clones with
K14+K8 basal cells mixed with K8+K14 luminal cells (Fig-
ures 6D and 6E). These data suggest that, upon turning on
EN in WVs, the EN oncoprotein could drive abnormal
basal differentiation (e.g., upregulation of K14) directly
from WV luminal cells, eventually leading to the develop-
ment of mammary tumors with basal differentiation.
Overall, these data demonstrate that, under the influence
of different oncogenic insults, WV luminal cells can un-
dergo abnormal differentiation, including basal differenti-ation. It was shown recently that mammary tumors that
developed in Wap-Cre;EN, MMTV-PyMT, and MMTV-Neu
mice resemble human HER2-enriched, luminal B, and
luminal A breast cancers at the molecular level, respec-
tively, and all three models highly express a gene signature
composed of many genes involved in alveolar function
(Pfefferle et al., 2013). Thus, it is likely that these three
models may share the same cellular origin, and our data
provide support for a model in which a common luminal
subpopulation enriched with long-lived APs may give rise
to distinct breast cancer subtypes, when transformed by
different oncogenic events.DISCUSSION
Whether the luminal MEC lineage in adults is sustained by
lineage-restricted LuSCs (Van Keymeulen et al., 2011) or by
bipotent basal stem cells (Rios et al., 2014; Wang et al.,
2015) in the physiological setting has become a topic of
intense debate. Nevertheless, one common observation
that started to emerge was evidence for long-lived LuSCs/
LPs that could sustain the luminal lineage in vivo, yet their
identity and role in breast cancer remained largely elusive.
Our study uncovered that (Ad-)Wap-Cre-marked MECs in
virgin females (i.e., WVs) are luminal MECs enriched
with a pre-existing population of long-lived LPs committed
to the alveolar luminal sub-lineage. In contrast to the pre-
vious finding in parous females for PI-MECs, we foundStem Cell Reports j Vol. 5 j 60–74 j July 14, 2015 j ª2015 The Authors 69
that, during pregnancy and lactation, these WVs only pro-
duced ALs, but not myoepithelial cells, in their native
habitat. This observation is consistent with a recent clonal
analysis study based on K5-rtTA/TetO-Cre and a multicolor
Cre-reporter, which demonstrated different cellular origins
of luminal and myoepithelial cells within individual al-
veoli (Rios et al., 2014).
WVs appear to be the target of recently revealed paracrine
basal-to-luminal cell signaling controlled by p63 (Forster
et al., 2014), and they overlap with LPs defined by either
Elf5-based (Rios et al., 2014) orNotch1-based lineage tracing
(Rodilla et al., 2015).WVsmay represent the classic APs that
work together with the two novel MEC subpopulations re-
vealed by Notch2-based genetic marking (i.e., S [small] and
L [large] cells) (Sale et al., 2013), for the formationof alveolar
clusters in response to alveologenic signals. Furthermore,
due to the self-sustained, long-lived nature of WVs, our
study provides an alternativemodel to explain the develop-
mental origin of PI-MECs. Rather than derived from de-dif-
ferentiation of secretory alveolar cells that survived involu-
tion, PI-MECs detected via Wap-Cre might represent a
combination of equipotent APs, either marked by Wap-Cre
at the virgin stage (i.e., WVs) or freshly marked by Wap-
Cre during late gestation (i.e., the second wave of genetic
marking when the Wap promoter activity is dramatically
upregulated; Figure 7A). These APs may be intrinsically
resistant to involution. As there should be a lot more of
them freshly labeled by Wap-Cre during late gestation
(due to much higherWap activity at this stage) than those
pre-labeled at the virgin stage, it would appear as if a larger
population of Wap-Cre-marked long-lived MECs emerged
only after parity (Wagner et al., 2002). This model is sup-
ported by a recent study characterizing parous PI-MECs us-
ingWap-Cremice (Chang et al., 2014). Lastly, the following
also should be pointed out: (1) our model does not exclude
the possibility that PI-MECs also canbe derived fromde-dif-
ferentiation of mature secretory ALs that survive involu-
tion; (2) our model does not suggest that nulliparous WVs
and parous PI-MECs are identical, and, in fact, parity is ex-
pected tohave a profound effect on this progenitor cell line-
age (in support of this, it was shown recently that, depend-
ing on the timing of acquiring premalignant lesions and of
pregnancy, the Wap-marked alveolar cell population was
the target cell mediating the dual roles of pregnancy in
increasing or reducing breast cancer risks [Haricharan
et al., 2013, 2014]); and (3) our model does not rule out a
possibility that WVs may include LuSCs that can give rise
to both ductal luminal cells and APs.
Although MaSCs (i.e., bipotent basal stem cells) were
initially hypothesized as cells of origin of breast cancer,
recent studies suggested thatmost breast cancers, including
basal-like breast cancer (BLBC), might originate from
luminal cells (Skibinski and Kuperwasser, 2015). In partic-70 Stem Cell Reports j Vol. 5 j 60–74 j July 14, 2015 j ª2015 The Authorsular, human LPs have been suggested as the cellular origin
of BLBC with BRCA1 mutation (Lim et al., 2009; Proia
et al., 2011), an observation supported by mouse modeling
(Molyneux et al., 2010). Our in vivo data provided evidence
to support that WVs, a subpopulation of CD61+ LPs, also
could serve as cells of origin of breast cancer. Several proper-
ties of these cells, such as resistance to involution and self-
renewal capacity, may contribute to their increased risk to
serve as cells of origin of breast cancer.
Recent lineage-tracing studies revealed that bipotent
basal stem cells could contribute to the luminal lineage
in vivo (Rios et al., 2014; Wang et al., 2014). Due to their
long-lived nature, it is possible that these bipotent stem
cells are the cell type in which an initiating mutation is ac-
quired (i.e., cells of mutation). However, it is also possible
that breast cancermay not initiate directly from suchmuta-
tion-bearing bipotent basal stem cells; instead, breast can-
cer may initiate from more committed progenitors (i.e.,
cells of origin), when they inherit the initiating mutation
from their parental bipotent stem cells. This concept was
described previously in the setting of glioma (Liu et al.,
2011). Furthermore, since our study suggests that WVs are
long-lived cells, one could argue that there would be a
long time window for them to acquire and accumulatemu-
tations as well, making it possible for them to serve as both
cells ofmutationandcells of originofbreast cancer.Ofnote,
our study does not suggest that WVs are the only cells of
origin of breast cancer; ductal progenitors also may serve
as cells of origin of breast cancer (Jeselsohn et al., 2010).
Finally, although the normal fate of WVs is to give rise
to ALs under the influence of ovarian and pregnancy
hormones, upon transformation by different oncogenes,
they can undergo aberrant luminal-to-luminal or luminal-
to-basal differentiation, eventually leading to the develop-
ment of heterogeneous mammary tumors (Figure 7B).
Overall, our study provides direct support for a luminal sub-
population enriched with APs as the cellular origin of mul-
tiple subtypes of breast cancers, and it may have important
implications for understanding the cell of origin and het-
erogeneity of breast cancer. As reproductive history of an in-
dividual has a profound impact on her lifetime breast can-
cer risk, identification of a long-lived MEC subpopulation
enriched with APs, which are excellent candidate target
cells for mediating pregnancy-induced risk changes, may
lead to novel strategies to prevent and treat breast cancer.EXPERIMENTAL PROCEDURES
Mouse Strains, Ovariectomy, and Mammary Gland
Intraductal Injection
Wap-Cre mouse was obtained from the Mouse Models of Human
Cancers Consortium (MMHCC) repository. R26YFP, R26lz,
MMTV-Neu, and MMTV-PyMT mice were purchased from the
Figure 7. Proposed Models for Normal and Abnormal Fates of WVs
(A) Schematic diagrams show AP cell fate mapping using constitutive Wap-Cre;R26YFP mice (top) and the Ad-Wap-Cre-based lineage-
tracing approach (bottom).
(B) Schematic diagram shows abnormal (during cancer development) fates of WVs. Arrow and arrowhead indicate abnormal differentiation
of WVs to K14+K8+ and K14+K8 basal-like cells, respectively.Jackson Laboratory. EN conditional knockin mouse was generated
previously (Li et al., 2007). All mice were under a pure FVB back-
ground unless otherwise indicated. Ovariectomy was performed
on 10-week-oldWap-Cre;R26YFP virginmice and analyzed 8 weeksafter surgery. Intraductal injection of Ad-Cre was performed as
described previously (Tao et al., 2014). All animal experiments
were approved by the Institutional Animal Care and Use Commit-
tee (IACUC).Stem Cell Reports j Vol. 5 j 60–74 j July 14, 2015 j ª2015 The Authors 71
Mammary Gland Cell Preparation, FACS Analysis, and
Cell Sorting
Thoracic and inguinal MGs were dissected and cell suspensions
were prepared as previously described (Shackleton et al., 2006).
Flow cytometric analysis was performed with an Accuri C6
analyzer (BD Biosciences) and analyzed with CFlow (BD Biosci-
ences), or it was performed with a DXP11 flow cytometer and
analyzed with FlowJo. FACS sorting was performed with a
FACSAria sorter (BD Biosciences).
Whole-Mount Staining, IHC and IF Staining,
and Clonal Analysis
Whole mounts of MGs of sham and ovariectomized mice were
fixed and processed as previously described (Jones et al., 1996).
IHC and IF staining of MG tissue was performed on inguinal
MGs that were fixed in 10% formalin (Fisher Scientific) and
embedded in paraffin. FACS-sorted cells used for IF were fixed in
4% paraformaldehyde and permeabilized by 0.5% Triton X-100.
For determination of the clone size of YFP-marked cells in the
MG of Wap-Cre;R26YFP adult virgin females, at least 100 YFP+
clones (single cell, two cells, or more than two cells) were counted
in four different mice. In vivo clonal analysis was performed as
described previously (Tao et al., 2014).
Microarray Analysis
Total RNA from sorted MECs was prepared by the RNeasy kit
(QIAGEN) and amplified with the Ovation RNA Amplification Sys-
tem V2 (NuGEN). Mouse Genome 430 2.0 Array (Affymetrix) was
used to generate the expression profiles. All arrays were normalized
by dCHIP, and PCA was performed by using the PCA module in
GenePattern (http://www.broadinstitute.org/cancer/software/
genepattern/).
qRT-PCR
For qRT-PCR, total RNA from sorted MEC subsets was prepared by
the RNeasy kit and cDNA was generated with iScript (Bio-Rad) ac-
cording to the manufacture’s protocol. PCR was performed using
FastStart SYBR Green Master (Roche).
Ad-Wap-Cre Adenovirus Vector Construction and
Adenovirus Production
Mouse Wap promoter (Wagner et al., 1997) was amplified from
mouse genomic DNA. The resultant PCR fragment was inserted
into adenovirus shuttle vector pAd5 (Gene Transfer Core of the
University of Iowa) to drive expression of Cre recombinase with
a nuclear localization sequence (nlsCre, Addgene). Ad-Wap-Cre
adenovirus was produced as described previously (Tao et al., 2014).
Statistics
Student’s t test was used to calculate the p values. Data were re-
ported as mean ± SEM.
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